Carmot Therapeutics is focused on the discovery and development of disease-modifying therapies for patients living with metabolic diseases and cancer. Carmot applies Chemotype Evolution (CE), a pioneering drug discovery platform, in combination with unique biological expertise to identify innovative and superior therapeutics.

Register for Details

For more details on financing and valuation for Carmot Therapeutics, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

What is Carmot Therapeutics's ticker symbol?

Carmot Therapeutics does not currently have an official ticker symbol because this company is still private. Register today to connect with our Private Market Specialists and learn more about new pre-IPO investment opportunities.

What is Carmot Therapeutics's stock price?

The stock price for Carmot Therapeutics will be known as it becomes public. Here are similar public companies: HealthStream (NAS: HSTM), Doximity (NYS: DOCS), Zymergen (NAS: ZY), Sight Sciences (NAS: SGHT).

Carmot Therapeutics Funding Rounds and Last Known Valuation

Date Funding Round Funding Raised Price per Share Last Known Valuation
5/25/2023 Series E $150MM raised $XXX.XX $XXX.XX
8/26/2022 Series D and D-1 $160.67MM raised $XXX.XX $XXX.XX
9/30/2020 Series C $46.88MM raised $XXX.XX $XXX.XX
1/17/2018 Series B $12.59MM raised $XXX.XX $XXX.XX
4/7/2010 Series A $2.16MM raised $XXX.XX $XXX.XX
Based on primary financings
Powered by Forge Data

Learn more about Carmot Therapeutics

Forge green plus iconForge green minus icon

What is Carmot Therapeutics funding to date?

Carmot Therapeutics has raised $372.31MM to date.
Forge green plus iconForge green minus icon

When was Carmot Therapeutics founded?

Carmot Therapeutics was founded in 2008.
Forge green plus iconForge green minus icon

Can you invest in Carmot Therapeutics?

Carmot Therapeutics is a privately held company and is not publicly traded on NYSE or NASDAQ in the U.S. To buy pre-IPO shares of a private company, you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.

Forge green plus iconForge green minus icon

Can you sell Carmot Therapeutics share pre-IPO?

If you own Carmot Therapeutics pre-IPO shares and are considering selling, you can find what your shares could be worth on Forge’s secondary marketplace.

Our Private Market Specialists are available to answer any questions you might have and can help connect you with a buyer from our network of 125,000 accredited investors and institutions. You can also learn more about how to sell your private shares before getting started.

Forge green plus iconForge green minus icon

Is Carmot Therapeutics a publicly traded company?

Carmot Therapeutics is a private company and not publicly traded.

If you are interested in buying or selling private company shares, you can register with Forge today for free to explore your options. Registering gives you access to one of our Private Market Specialists who can guide you through the process of buying or selling. Learn more about how Forge might help you buy pre-IPO shares or sell pre-IPO shares.

Updated on: Nov 15, 2023


Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.